Skip to content
Sunday, November 15, 2026
London Mega Direct

Individuals Discontinuing Weight-Loss Jabs Put On Weight at a Quadrupled Rate Than People Using Diet and Exercise

Illustration of medical injection and weighing machine
Obesity treatment often requires long-term strategies.

New research indicates that people who come off blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop conventional lifestyle regimens.

Findings released in a major health publication points out that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month once they quit.

"People buying such medications must be aware of the risk of quick rebound weight gain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.

Such speed of regain implies a return to original mass in about one and a half years.

Weighing Approaches

The analysis, which looked at dozens of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with older methods.

The team emphasize that people who shed pounds through diet and exercise generally have a more gradual creep back—around 0.1 kg a month—once they finish.

Understanding the Fast Regain

Experts propose the mode of action of the drugs is key to understanding the accelerated rebound.

These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Long-term administration of GLP-1 levels several times higher than normal may cause the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication leads to appetite is uncontrolled, making excessive eating much more probable."

A Chronic Issue?

The NHS advise the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.

Professionals contend that, given the high risk of relapse, the treatment should be considered long-term.

This opinion is reinforced by drug manufacturers, who state that the findings "underscore the long-term nature of obesity," comparing it to managing diseases like diabetes.

User Testimonies

Individuals who have stopped the jabs describe a sudden resurgence of cravings.

"I experienced a switch that goes on and you're instantly starving," said a patient.

The struggle is worsened if individuals have not adopted sustainable dietary or behavioural changes during treatment.

Growing Adoption

Figures suggest that millions of people in the UK have used weight-loss jabs in the past year, with desire being substantial.

  • Adoption is greater among females than males.
  • The 40s and 50s demographic shows the highest level of interest.
  • A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, experts stress that while these medications are powerful agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on ongoing lifestyle support.

The writer

Dana Wilson

Travel writer and London enthusiast exploring the city's vibrant culture and history.

London Mega Direct

Type to search articles.